Procept BioRobotics Corp

+0.38 (+1.18%)
5:03:53 PM EDT: $32.46 0.00 (0.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)1.46B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$24.39 Million
Adjusted EPS-$0.58
See more estimates
10-Day MA$32.54
50-Day MA$36.07
200-Day MA$39.56
See more pivots

Procept BioRobotics Corp Stock, NASDAQ:PRCT

900 Island Drive, Suite 170, Redwood City, California 94065
United States of America
Phone: +1.650.232.7200
Number of Employees: 428


PROCEPT BioRobotics Corp. is a commercial-stage surgical robotics company, which engages in the development of transformative solutions in urology. It manufactures and sells the AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery, with an initial focus on treating BPH. The firm's proprietary AquaBeam Robotic System employs a single-use disposable handpiece to deliver its Aquablation therapy, which combines real-time, multidimensional imaging, personalized treatment planning, automated robotics and heat-free waterjet ablation for targeted and rapid removal of prostate tissue. The company was founded by Nikolai Aljuri and Rodney C. Perkins in 2007 and is headquartered in Redwood City, CA.